Emtricitabine/TDF
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72189-403 -
Package NDC
72189-403-03 -
Application number
ANDA090513 -
SPL ID
2c4cdf7a-45da-784b-e063-6294a90a82b9 -
SPL set ID
ef1a90ca-92bc-3787-e053-2a95a90a58ec -
UNII
OTT9J7900I -
UNII
G70B4ETF4S -
RxCUI
476556
What the source publishes
- Labeler
- Direct_Rx
- Active ingredients
- Emtricitabine/TDF
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Emtricitabine/TDF",
"splId": "2c4cdf7a-45da-784b-e063-6294a90a82b9",
"labels": [
{
"setId": "ef1a90ca-92bc-3787-e053-2a95a90a58ec",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ef1a90ca-92bc-3787-e053-2a95a90a58ec",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ef1a90ca-92bc-3787-e053-2a95a90a58ec"
}
],
"routes": [
"ORAL"
],
"labeler": "Direct_Rx",
"finished": true,
"packaging": [
{
"sample": false,
"description": "3 TABLET, FILM COATED in 1 BOTTLE (72189-403-03)",
"package_ndc": "72189-403-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20221205"
}
],
"productId": "72189-403_2c4cdf7a-45da-784b-e063-6294a90a82b9",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "72189-403",
"deaSchedule": null,
"genericName": "Emtricitabine/TDF",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TENOFOVIR DISOPROXIL FUMARATE",
"strength": "300 mg/1"
},
{
"name": "EMTRICITABINE",
"strength": "200 mg/1"
}
],
"applicationNumber": "ANDA090513",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20221205",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175462",
"M0015066",
"N0000009947"
],
"unii": [
"OTT9J7900I",
"G70B4ETF4S"
],
"rxcui": [
"476556"
],
"spl_set_id": [
"ef1a90ca-92bc-3787-e053-2a95a90a58ec"
],
"pharm_class_cs": [
"Nucleosides [CS]"
],
"pharm_class_epc": [
"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Nucleoside Reverse Transcriptase Inhibitors [MoA]"
],
"manufacturer_name": [
"Direct_Rx"
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72189-403_2c4cdf7a-45da-784b-e063-6294a90a82b9"